These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. Corti S, Locatelli F, Papadimitriou D, Del Bo R, Nizzardo M, Nardini M, Donadoni C, Salani S, Fortunato F, Strazzer S, Bresolin N, Comi GP. Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986 [Abstract] [Full Text] [Related]
3. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. Garbuzova-Davis S, Willing AE, Zigova T, Saporta S, Justen EB, Lane JC, Hudson JE, Chen N, Davis CD, Sanberg PR. J Hematother Stem Cell Res; 2003 Jun; 12(3):255-70. PubMed ID: 12857367 [Abstract] [Full Text] [Related]
4. Lack of caspase-dependent apoptosis in spinal motor neurons of the wobbler mouse. Bigini P, Atzori C, Fumagalli E, Cagnotto A, Barbera S, Migheli A, Mennini T. Neurosci Lett; 2007 Oct 16; 426(2):106-10. PubMed ID: 17890007 [Abstract] [Full Text] [Related]
8. Cell therapy and stem cells in animal models of motor neuron disorders. Hedlund E, Hefferan MP, Marsala M, Isacson O. Eur J Neurosci; 2007 Oct 16; 26(7):1721-37. PubMed ID: 17897390 [Abstract] [Full Text] [Related]
12. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice. Tanaka K, Okada Y, Kanno T, Otomo A, Yanagisawa Y, Shouguchi-Miyata J, Suga E, Kohiki E, Onoe K, Osuga H, Aoki M, Hadano S, Itoyama Y, Ikeda JE. Exp Neurol; 2008 Jun 16; 211(2):378-86. PubMed ID: 18423451 [Abstract] [Full Text] [Related]
14. Animal models for motor neuron disease. Green SL, Tolwani RJ. Lab Anim Sci; 1999 Oct 16; 49(5):480-7. PubMed ID: 10551448 [Abstract] [Full Text] [Related]
15. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. Tu PH, Gurney ME, Julien JP, Lee VM, Trojanowski JQ. Lab Invest; 1997 Apr 16; 76(4):441-56. PubMed ID: 9111507 [Abstract] [Full Text] [Related]
16. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis. Yoo YE, Ko CP. Exp Neurol; 2011 Sep 16; 231(1):147-59. PubMed ID: 21712032 [Abstract] [Full Text] [Related]
17. Genetic transfer of the wobbler gene to a C57BL/6J x NZB hybrid stock: natural history of the motor neuron disease and response to CNTF and BDNF cotreatment. Ishiyama T, Klinkosz B, Pioro EP, Mitsumoto H. Exp Neurol; 1997 Nov 16; 148(1):247-55. PubMed ID: 9398466 [Abstract] [Full Text] [Related]
18. Plasma Derived From Human Umbilical Cord Blood Modulates Mitogen-Induced Proliferation of Mononuclear Cells Isolated From the Peripheral Blood of ALS Patients. Eve DJ, Ehrhart J, Zesiewicz T, Jahan I, Kuzmin-Nichols N, Sanberg CD, Gooch C, Sanberg PR, Garbuzova-Davis S. Cell Transplant; 2016 Nov 16; 25(5):963-71. PubMed ID: 26159164 [Abstract] [Full Text] [Related]
19. Multiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice. Sironi F, Vallarola A, Violatto MB, Talamini L, Freschi M, De Gioia R, Capelli C, Agostini A, Moscatelli D, Tortarolo M, Bigini P, Introna M, Bendotti C. Stem Cell Res; 2017 Dec 16; 25():166-178. PubMed ID: 29154076 [Abstract] [Full Text] [Related]
20. Cord blood as a potential therapeutic for amyotrophic lateral sclerosis. Garbuzova-Davis S, Ehrhart J, Sanberg PR. Expert Opin Biol Ther; 2017 Jul 16; 17(7):837-851. PubMed ID: 28443372 [Abstract] [Full Text] [Related] Page: [Next] [New Search]